Barclays Maintains Underweight on Molina Healthcare, Lowers Price Target to $178

Benzinga · 4d ago
Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and lowers the price target from $180 to $178.